Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Operating Leases (2021 - 2026)

Biohaven has reported Operating Leases over the past 6 years, most recently at $38.4 million for Q1 2026.

  • Quarterly results put Operating Leases at $38.4 million for Q1 2026, up 24.54% from a year ago — trailing twelve months through Mar 2026 was $38.4 million (up 24.54% YoY), and the annual figure for FY2025 was $40.0 million, up 21.89%.
  • Operating Leases reached $38.4 million in Q1 2026 per BHVN's latest filing, down from $40.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $40.4 million in Q3 2025 and bottomed at $25.3 million in Q3 2024.
  • Median Operating Leases over the past 5 years was $29.8 million (2023), compared with a mean of $31.1 million.
  • The largest annual shift saw Operating Leases skyrocketed 845.02% in 2022 before it decreased 10.51% in 2024.
  • Over 5 years, Operating Leases stood at $30.6 million in 2022, then dropped by 9.85% to $27.6 million in 2023, then increased by 18.91% to $32.8 million in 2024, then grew by 21.89% to $40.0 million in 2025, then fell by 3.99% to $38.4 million in 2026.
  • Business Quant data shows Operating Leases for BHVN at $38.4 million in Q1 2026, $40.0 million in Q4 2025, and $40.4 million in Q3 2025.